Greenhill provided an exceptional solution for our offering that was simple, streamlined, and efficient for both the investors and the Company.  A key for us was the 24/7 access for investors to complete their information in an encrypted and secure online setting that resulted in e-signatures and support for all parties.  Highly recommend Greenhill and the entire team for investor management.

Our company presently engages the services of Greenhill Equity Solutions for all our needs as a private reporting issuer.   

Our company is a VC biotech conducting scientific research on small molecules for applications in human health, including infectious disease involving microbial pathogens, fungal infections and viral infections.

We are pleased with the services that we receive as it prepares the company for a possible public listing in the future.